KEY FEATURES
| Full Name | Cytokeratin 1 |
|---|---|
| Synonym | KRT1; EHK1; K1; KRT1A; KRT1-A; Keratin 1; Epidermolytic Hyperkeratosis; Keratin, type II cytoskeletal 1; 67 kDa cytokeratin; Type-II keratin Kb1 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.15-10ng/mL |
| Sensitivity | 0.07ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human CK1 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human CK1. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human CK1 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human CK1, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human CK1. You can calculate the concentration of Human CK1 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human CK1 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.46 | 1 | 4.75 | 0.5 | 1.03 | 4.63 |
| Standard deviation | 0.02 | 0.05 | 0.23 | 0.03 | 0.05 | 0.21 |
| CV(%) | 5.34 | 5.39 | 4.87 | 6.42 | 4.58 | 4.6 |
RECOVERY
The recovery of Human CK1 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 89-102 | 94 |
| EDTA plasma (n=8) | 89-103 | 95 |
| Cell culture media (n=8) | 95-109 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human CK1 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with KRT1 ELISA Kits
| CTNNB1 ELISA Kit | publications with KRT1 and CTNNB1 |
| FLG ELISA Kit | publications with KRT1 and FLG |
| PLAUR ELISA Kit | publications with KRT1 and PLAUR |
| IVL ELISA Kit | publications with KRT1 and IVL |
Pathways associated with KRT1 ELISA Kit
| Corticotropin-releasing Hormone Pathway | Corticotropin-releasing Hormone Pathway |
| Regulation Of Wnt-mediated Beta Catenin Signaling And Target Gene Transcription Pathway | Regulation Of Wnt-mediated Beta Catenin Signaling And Target Gene Transcription Pathway |
Diseases associated with KRT1 ELISA Kit
| Neoplasms | publications with KRT1 and Neoplasms |
| Skin Neoplasms | publications with KRT1 and Skin Neoplasms |
| Hyperkeratosis, Epidermolytic | publications with KRT1 and Hyperkeratosis, Epidermolytic |
| Carcinoma | publications with KRT1 and Carcinoma |
| Inflammation | publications with KRT1 and Inflammation |
| Hyperplasia | publications with KRT1 and Hyperplasia |
| Carcinoma, Squamous Cell | publications with KRT1 and Carcinoma, Squamous Cell |
| Keratoderma, Palmoplantar, Epidermolytic | publications with KRT1 and Keratoderma, Palmoplantar, Epidermolytic |
| Immune System Diseases | publications with KRT1 and Immune System Diseases |
| Necrosis | publications with KRT1 and Necrosis |
Organs/Tissues associated with KRT1 ELISA Kit
| Skin | publications with KRT1 and Skin |
| Blood | publications with KRT1 and Blood |
| Mouth | publications with KRT1 and Mouth |
| Thymus | publications with KRT1 and Thymus |
| Lung | publications with KRT1 and Lung |
| Mammary Gland | publications with KRT1 and Mammary Gland |
| Brain | publications with KRT1 and Brain |
| Bladder | publications with KRT1 and Bladder |
| Uterus | publications with KRT1 and Uterus |
| Heart | publications with KRT1 and Heart |